|
PSMD10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.881200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.284200E-02 |
| Normal-vs-Stage2 |
6.243200E-01 |
| Normal-vs-Stage3 |
3.358100E-02 |
| Normal-vs-Stage4 |
1.846370E-01 |
| Stage1-vs-Stage2 |
2.441600E-01 |
| Stage1-vs-Stage3 |
3.433600E-04 |
| Stage1-vs-Stage4 |
8.369400E-01 |
| Stage2-vs-Stage3 |
3.086800E-01 |
| Stage2-vs-Stage4 |
3.423600E-01 |
| Stage3-vs-Stage4 |
4.462100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.759000E-01 |
| Normal-vs-AfricanAmerican |
9.262400E-01 |
| Normal-vs-Asian |
6.901200E-01 |
| Caucasian-vs-AfricanAmerican |
4.323600E-01 |
| Caucasian-vs-Asian |
4.782400E-01 |
| AfricanAmerican-vs-Asian |
7.248200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.967900E-02 |
| Normal-vs-Female |
1.536440E-02 |
| Male-vs-Female |
2.4216999999993E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.705800E-01 |
| Normal-vs-Extreme_Weight |
9.384200E-02 |
| Normal-vs-Obese |
6.970600E-01 |
| Normal-vs-Extreme_Obese |
6.388300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.719800E-01 |
| Normal_Weight-vs-Obese |
3.569200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.320200E-01 |
| Extreme_Weight-vs-Obese |
8.044000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.752800E-01 |
| Obese-vs-Extreme_Obese |
1.994610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.726000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.151600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.821900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.627800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.289600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.467770E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.777500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.875700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.844000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.711600E-02 |
| Normal-VS-Type2 PRCC |
8.413200E-01 |
| Normal-VS-KIRP CIMP |
7.179000E-03 |
| Normal-VS-Unclassified PRCC |
4.564000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.318600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.055810E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.036500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.822200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.350200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.626390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.797600E-01 |
| Normal-vs-N1 |
1.293370E-01 |
| Normal-vs-N2 |
8.549600E-01 |
| N0-vs-N1 |
6.156000E-02 |
| N0-vs-N2 |
6.880400E-01 |
| N1-vs-N2 |
6.342200E-01 |
|
|
